Table of Contents
Print

Are circadian rhythm genes altered in ADHD transcriptomics? 

Yes, emerging research suggests that ADHD circadian genes may play a significant role in the disorder’s biology, with disruptions in the sleep-wake cycle often seen in individuals with ADHD. Transcriptomics, the study of gene expression, is shedding light on how circadian rhythm genes are altered in ADHD and how these changes may contribute to symptoms like inattention, hyperactivity, and impulsivity. 

Understanding the role of circadian genes in ADHD 

Circadian rhythm genes regulate the body’s internal clock, controlling the sleep-wake cycle and influencing critical processes like mood, attention, and energy levels. In individuals with ADHD, these genes may not function properly, leading to irregular sleep patterns and difficulties with focus and impulse control. 

Key circadian genes include: 

  • CLOCK A central player in maintaining the body’s daily rhythm. Dysregulation of CLOCK gene expression has been linked to ADHD symptoms, especially inattention and hyperactivity. 
  • PER1/2 and BMAL1 These genes work together to control the biological clock. Altered expression of PER and BMAL1 has been observed in individuals with ADHD, particularly in those who experience sleep disturbances. 
  • ARNTL This gene helps regulate the timing of the circadian clock. Changes in its expression could explain difficulties with sleep timing, often reported in ADHD. 

How transcriptomics is revealing these alterations 

Transcriptomics reveals these alterations by mapping changes in gene expression patterns that influence brain function and ADHD symptoms. 

Gene expression profiling  

By using transcriptomics, researchers can analyse the expression of circadian genes in individuals with ADHD. These studies have shown that ADHD patients often exhibit differences in the expression of circadian genes, potentially contributing to disrupted sleep patterns and attentional difficulties. 

Sleep-wake cycle and ADHD symptoms 

 Disruptions in circadian rhythms can lead to poor sleep quality, which in turn affects attention and cognitive performance. Transcriptomics can help identify which circadian genes are most involved in ADHD, shedding light on how sleep problems might exacerbate symptoms. 

Epigenetic factors 

The expression of circadian genes may also be influenced by epigenetic changes. Environmental factors like stress or poor sleep could modify how these genes are regulated, further complicating ADHD treatment. 

Why this matters for ADHD treatment 

This matters for ADHD treatment because understanding gene expression changes can guide more personalised and effective therapies. 

Improving sleep management  

Understanding how circadian genes are altered in ADHD could lead to more targeted treatments for sleep disturbances, such as chronotherapy or medication that directly targets the biological clock. 

Personalised therapies  

If certain circadian gene patterns are linked to specific ADHD subtypes, transcriptomic analysis may allow for more personalised and effective treatments that consider not just ADHD symptoms but also the individual’s sleep patterns and circadian health. 

Long-term outcomes  

Addressing circadian rhythm disruptions early on could improve not just ADHD symptoms, but also overall health and quality of life, as better sleep can positively impact cognitive performance, mood, and emotional regulation. 

By examining ADHD circadian genes through transcriptomics, we can uncover the biological mechanisms behind sleep-related symptoms and refine ADHD treatment strategies. This new insight holds promise for more holistic care that addresses both gene expression and sleep health. 

Visit providers like ADHD Certify for personal consultations that integrate circadian rhythm insights into ADHD care. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic studies and biomarkers.

Victoria Rowe, MSc, author for my patient advice - mypatientadvice.co.uk

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS, author and a reviewer for my patient advice - mypatientadvice.co.uk

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.